Chimeric Antigen Receptor (CAR) T-Cell Therapy
Chimeric Antigen Receptor (CAR T-Cell) is a new form of compassionate-use cancer immunotherapy with the following benefits:
- Enable recognition and targeting of specific cancer cells
- Reduced side effects from treatment, as healthy cells are left undamaged
- For late-stage cancers or when usual treatment fails
Disclaimer:
There are never any guarantees with all services and products as there are too many variables